---
title: "29 Biotech Investors in New York (Nov 2026): 24 in New York City"
last_updated: "2026-11-06"
rows: "29"
free_rows: "14"
source: "SEC filings"
canonical: "https://theinvestordatabase.com/lists/biotech-investors-in-new-york/"
---

# 29 biotech investors in New York, including 24 in New York City

We list 29 biotech investors in New York as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are New York (23), Tuxedo Park (1) and Hicksville (1). 24 of the 29 are in the New York City metro area, so this page is also our list of biotech investors in New York City.

- 29 investors
- 22 with a fund filing or dated deal in the last 12 months
- $66M median fund size on file (SEC Form D, 16 firms)
- 157 named decision-makers on file

## First 14 of 29 biotech investors in New York

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Digitalis Ventures | VC firm | New York, NY | Seed | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| HOF Capital | VC firm | New York, NY | Any stage | Biotech, AI, Fintech, Consumer | New fund, Aug 2026 | $300M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/hof-capital/ |
| Union Square Ventures | VC firm | New York, NY | Seed, Series A | Biotech, AI, Generalist, Robotics | New deal, Oct 2026 | $3M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/union-square-ventures/ |
| Jeito | VC firm | New York, NY |  | Biotech, Healthtech | New deal, Jun 2026 |  | 2026-11-05 | https://theinvestordatabase.com/investors/jeito/ |
| Aisling Capital | VC firm | New York, NY | Seed | Biotech, Healthtech, Food and Beverage, Medtech | Portfolio news, Jul 2026 | $64M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/aisling-capital/ |
| Ghic | VC firm | New York, NY |  | Biotech, Healthtech, Impact, Medtech | New fund, May 2026 | $270M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/ghic/ |
| Arcventis Health Partners | VC firm | New York, NY | Growth | Biotech, Healthtech, Medtech | New fund, Sep 2026 | $33M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/arcventis-health-partners/ |
| Eckuity Capital | VC firm | New York, NY | Growth | Biotech, Healthtech, Medtech | New fund, Jun 2026 | $300M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/eckuity-capital/ |
| Apple Tree Venture | VC firm | New York, NY | Pre-seed, Seed, Series A, Series B, Growth | Biotech, Healthtech | Portfolio news, Sep 2025 | $3.5B (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/apple-tree-venture/ |
| Antler | Accelerator | New York, NY | Pre-seed, Seed, Series A, Series B, Growth | Biotech, AI, Healthtech, Consumer | New deal, Aug 2026 | $90M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/antler/ |
| MBX Capital | VC firm | Tuxedo Park, NY | Seed | Biotech, Healthtech, Medtech | New deal, Jul 2026 | $50M (SEC Form D, 2023) | 2026-11-05 | https://theinvestordatabase.com/investors/mbx-capital/ |
| Overlap Holdings | VC firm | Hicksville, NY | Seed, Series A, Series B | Biotech, AI, Energy, Climate Tech | New fund, Oct 2026 | $16M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/overlap-holdings/ |
| Black Opal Ventures | VC firm | New York, NY |  | Biotech, Healthtech, SaaS, Medtech | New fund, Aug 2026 | $75M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/black-opal-ventures/ |
| Cerberus Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A, Series B | Biotech, AI, Industrial Tech, Quantum | New fund, Jun 2026 | $75M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/cerberus-ventures/ |

You are seeing 14 of 29. The full list adds 15 more investors and 157 named decision-makers.

Get all 29 investors and 157 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/biotech-investors-in-new-york
This page: https://theinvestordatabase.com/lists/biotech-investors-in-new-york/

## 24 biotech investors in New York City
19 of the 24 have a fund filing or a dated deal in the last 12 months; the median fund size on file is $75M (SEC Form D, 14 firms); the most recent fund filings are from Arcventis Health Partners (Sep 2026), HOF Capital (Aug 2026) and Union Square Ventures (Aug 2026); of the 16 with a stage on file, seed (10), growth-stage (7) and Series A (6); the count covers the metro area, by city: New York (23) and Brooklyn (1); the paid file holds 129 named decision-makers for them.
The first 5 in list order: Digitalis Ventures, HOF Capital, Union Square Ventures, Jeito and Aisling Capital.

## Method and limits
- Source: All 29 rows carry an SEC filing (Form D or Form ADV). All 29 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: head office in New York.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 29 rows: stage 21, sector 29, fund size 24, website 29. In the paid file: named decision-makers on 28 rows, firm email on 8, LinkedIn page on 10, check size on 0.

## Questions
### How many biotech investors in New York are there?
We list 29 as of November 2026. 22 of the 29 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (23), Tuxedo Park (1) and Hicksville (1).

### Which biotech investors in New York raised a new fund in the last 12 months?
12 of the 29 have a fund filing dated in the last 12 months. The most recent on this list are Overlap Holdings (Oct 2026), Arcventis Health Partners (Sep 2026) and HOF Capital (Aug 2026).

### What is the typical fund size of biotech investors in New York?
The median fund size on file for this list is $66M, across the 16 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 13 do not disclose a size there.

### How do I contact biotech investors in New York?
The paid file holds 157 named decision-makers across 28 of these 29 and a firm email for 8. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on biotech investors in New York come from?
All 29 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.